Condition (MeSH)
Eye Injuries
ClinicalTrials.gov lists 71 trials for Eye Injuries or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase (log scale)
23 of the 71 trials are tagged with Eye Injuries itself; the rest are tagged with a narrower condition beneath it.
When did Eye Injuries trials start? (21)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Phase 2
- Phase 2/3
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 7
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 3 |
| 2025 | 2 |
| 2024 | 7 |
| 2023 | 1 |
| 2022 | 6 |
| 2021 | 6 |
| 2020 | 5 |
| 2019 | 5 |
| 2018 | 5 |
| 2017 | 2 |
Showing 10 of 21 earlier years.
No forecast is made for this condition: it averages 4.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Prediction, not a registry value: median of 25 months from start to primary completion across 6 trials still running at the 2026-10-09 snapshot; registered median of 22 months across 31 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Eye Injuries trials in? (8)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 8 |
| Phase 1/2 | 2 |
| Phase 2 | 3 |
| Phase 2/3 | 4 |
| Phase 3 | 3 |
| Phase 4 | 1 |
| Not applicable | 26 |
| Observational | 24 |
How many Eye Injuries trials are recruiting? (7)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 2 |
| Recruiting | 8 |
| Active, not recruiting | 1 |
| Completed | 28 |
| Terminated | 5 |
Showing 5 of 7 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Eye Injuries trials? (3)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| CorNeat Vision Ltd. | 2 |
| Krystal Biotech, Inc. | 2 |
| Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. | 1 |
Interventions as named in the registry (15)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Artificial Tear | 2 |
| C: moxifloxacin | 1 |
| data collection | 1 |
| Low dose losartan | 1 |
| Topical Insulin | 1 |
Showing 5 of 15 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Eye Injuries trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Choroidal detachment and exudative detachment | 1 | 1 |
| Conjunctival retraction with dehiscence of prosthesis & possible corneal epithelial ingrowth | 1 | 1 |
| Covid 19 Infection | 1 | 1 |
| Dehiscence of prosthesis superiorly | 1 | 1 |
| Exposure of implant | 1 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Eye Injuries? (93)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Randomised controlled trial of adjunctive triamcinolone acetonide in eyes undergoing vitreoretinal surgery following open globe trauma: The ASCOT study. | The British journal of ophthalmology | 2024 | Yes |
| Economic evaluation of an adjunctive intraocular and peri-ocular steroid vitreoretinal surgery for open globe trauma: Cost-effectiveness of the ASCOT randomised controlled trial. | PloS one | 2024 | Yes |
| Badminton-related eye injuries: a systematic review. | Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention | 2023 | Yes |
| A new approach to categorization of ocular injury among U.S. Armed Forces. | MSMR | 2022 | Yes |
| Prognosis of Open Globe Injuries at a Tertiary Referral Center: The Modified Florida Ocular Trauma Score. | American journal of ophthalmology | 2022 | Yes |
Showing 5 of 93 publications.
Sub-conditions in MeSH (4)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence and rare-disease identity.